NCT02165566View on ClinicalTrials.gov

Humalog or Humulin for Intensive Insulin Therapy in Intensive Care Unit

PHASE4CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

March 31, 2014

Study Completion Date

May 31, 2014

Conditions
Hyperglycemia
Interventions
DRUG

Regular-insulin

patients are assigned in a random sequence to receive Regular-insulin or lispro-insulin infusion

DRUG

Lispro-insulin

patients are assigned in a random sequence to receive Regular-insulin or lispro-insulin infusion

Trial Locations (1)

Unknown

"University of ROme La Sapienza Rome Italy", Rome

All Listed Sponsors
lead

University of Roma La Sapienza

OTHER

NCT02165566 - Humalog or Humulin for Intensive Insulin Therapy in Intensive Care Unit | Biotech Hunter | Biotech Hunter